Results 151 to 160 of about 45,512 (293)
ABSTRACT Recent studies suggest that health literacy (HL) may play an important role in management of individuals living with severe obesity (BMI ≥ 40 kg/m2), but to date, there has been no attempt to synthesize characteristics and outcomes of these studies.
Andrea Xia +5 more
wiley +1 more source
Glioblastoma Subtypes Exhibit Distinct Migration Mechanics and Immune Responses. [PDF]
Shamsan GA +17 more
europepmc +1 more source
Targeting allele-specifico delle mutazioni NRAS nel Mieloma Multiplo
Il Mieloma Multiplo è la seconda neoplasia ematologica più comune ed è caratterizzata dall'espansione clonale di plasmacellule principalmente nel midollo osseo.
TASSIERI, ANNA
core
Investigation of Oncogenic Gene Mutation and Associated Protein Expression in Ameloblastic Carcinoma
ABSTRACT Objective This study aimed to investigate gene mutations in ameloblastic carcinoma (AC) including BRAF, KRAS, and PIK3CA, along with associated protein expressions of BRAF V600E, p‐ERK1/2, and p‐mTOR, which represent activation of MAPK/ERK and PI3K/mTOR pathways, respectively.
Puangwan Lapthanasupkul +4 more
wiley +1 more source
<i>TRAF7</i> mutations stabilize K/NRAS and hyperactivate MAPK signaling to cause CAFDADD neurodevelopmental defects. [PDF]
Xiao M +15 more
europepmc +1 more source
Abstract Background Extracellular vesicles (EVs), especially exosomes, are nanoparticles increasingly recognized as key regulators of intercellular communication in both physiological and pathological aspects. Despite rapid progress, inconsistencies in nomenclature, isolation, and characterization continue to restrict translational advancement.
Paras Ahmad +6 more
wiley +1 more source
Clinical Phenotype, Molecular Architecture, and Survival Follow-Up in NRAS- and KRAS-Mutated Juvenile Myelomonocytic Leukemia. [PDF]
Zhang B +13 more
europepmc +1 more source
Daraxonrasib and the era of pan-RAS inhibition: mechanisms, clinical advances, and resistance landscapes. [PDF]
Lou J, Zhang D.
europepmc +1 more source
Precision Medicine in Dermatology: MEK Inhibition and MAPK Pathway Modulation for Congenital Melanocytic Nevi. [PDF]
Forsyth A +7 more
europepmc +1 more source

